CCDRD AG has extensive experience with generic Budesonide/Formoterol inhalation product development compared to the available DPI and MDI reference products such as Symbicort®.
- 10 pharmacokinetic trials performed with Salmeterol/Fluticasone DPI and MDI inhalers in healthy subjects
- systemic safety and lung deposition trials
- highly experienced investigators and study teams in the phase I units available
- standardized training and clinical procedures
- intra-subject and residual variance data available